Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, March 15, 2012

‘PUFA–GPR40–CREB signaling’ hypothesis for the adult primate neurogenesis

Somebody needs to tell us how much saturated fat we should have in our system to allow neurogenesis.
http://www.sciencedirect.com/science/article/pii/S0163782712000173

Abstract

Despite the well-known effects of polyunsaturated fatty acids (PUFA) on synaptic plasticity, PUFA-modulated signaling mechanism is unknown especially in humans. In 2003, three groups reported that G protein-coupled receptor 40 (GPR40) induces Ca2+ mobilization in response to PUFA. Although GPR40 gene is abundantly expressed in the primate brain, it is negligible in the rodent brain. Diverse PUFA including docosahexaenoic acid (DHA) are in vitro ligands for GPR40, but nobody knows its downstream pathway. cAMP-response element binding protein (CREB) is a transcription factor transmitting extracellular signals to change gene expression. Although PUFA, transported by fatty acid binding proteins (FABP), directly phosphorylate CREB in rodents, hydrophobic PUFA cannot access to the nuclei in the primate neurons because of lack of a cargo protein. Ischemia-enhanced adult neurogenesis in monkeys showed concomitant upregulation of GPR40 and phosphorylated CREB, and localization of both in the neurogenic niche. Here, ‘PUFA–GPR40–CREB signaling’ hypothesis was highlighted as a regulator of adult neurogenesis specific for primates.

Abbreviations

  • AC, adenylyl cyclase;
  • AMPA, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid;
  • ARA, arachidonic acid;
  • BDNF, brain-derived neurotrophic factor;
  • BrdU, bromodeoxyuridine;
  • [Ca2+]i, intracellular Ca2+ concentration;
  • CaMK, calmodulin-dependent kinase;
  • cAMP, cyclic AMP;
  • CRE, cAMP response element;
  • CREB, cAMP response element-binding protein;
  • cPLA2, cytosolic phospholipase A2;
  • DAG, diacylglycerol;
  • DCX, doublecortin;
  • DG, dentate gyrus;
  • DGLA, dihomogammalinolenic acid;
  • DHA, docosahexaenoic acid;
  • EDTA, ethylenediamine tetraacetic acid;
  • EPA, eicosapentaenoic acid;
  • ER, endoplasmic reticulum;
  • FABP, fatty acid binding proteins;
  • GAP-43, growth-associated protein-43;
  • GCL, granular cell layer;
  • GPCR, G protein-coupled receptors;
  • GPR40, G protein-coupled receptor 40;
  • Gαq, G protein α-subunit of the Gq family;
  • Gq, G protein of the Gq family;
  • IGF, insulin-like growth factor;
  • IP3, inositol 1,4,5-trisphosphate;
  • iPLA2, Ca2+-independent phospholipase A2;
  • LT, leukotriene;
  • LTP, long-term potentiation;
  • MAPK, mitogen-activated protein kinase;
  • NFκB, nuclear factor κB;
  • NGF, nerve growth factor;
  • NHR, nuclear hormone receptors;
  • NMDA, N-methyl-d-aspartate;
  • pCREB, phosphorylated cAMP response element-binding protein;
  • PG, prostaglandin;
  • PGI, prostacyclin;
  • PIP2, phosphatidylinositol 4,5-bisphosphate;
  • PKA, protein kinase A;
  • PKC, protein kinase C;
  • PPAR, peroxysome proliferator-activated receptors;
  • PS, phosphatidylserine;
  • PLA2, phospholipase A2;
  • PLC, phospholipase C;
  • PPAR, peroxisome proliferator-activated receptors;
  • PSA–NCAM, polysialylated–neural cell adhesion molecule;
  • PUFA, polyunsaturated fatty acids;
  • RXR, retinoid X receptors;
  • SGZ, subgranular zone;
  • SNARE, soluble N-ethylmaleimide-sensitive-factor attachment protein receptor;
  • TrkB, neurotrophin tyrosine kinase receptor type 2;
  • TXA, thromboxane;
  • VEGF, vascular endothelial growth factor

Keywords

  • Adult neurogenesis;
  • Hippocampus;
  • Primate;
  • PUFA;
  • GPR40;
  • CREB;
  • BDNF

1 comment:

  1. Hypothesis Testing
    Define Hypothesis, what is Hypothesis? Define Hypothesis Testing, null Hypothesis,
    http://www.infoaw.com/article.php?articleId=952

    ReplyDelete